Premium
MacroGenics Inc (MGNX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Jay Philip SiegelInitié | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Mr. Scott T. JacksonIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Dr. Margaret A. LiuIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Ms. Meenu Chhabra KarsonIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Dr. William K. HeidenIndependent Chairman of the Board | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 114,75k | 3,38% |
| 2026-05-18 | Ms. Federica F. O'BrienIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Mr. Edward M. HurwitzIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 47,82k | 8,51% |
| 2026-05-18 | Dr. David C. StumpIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Dr. Karen Jean FerranteIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-02-15 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | 10,23k | 0,00 | Derivative Exercise and Retained Stock | - | 145,80k | 7,55% |
| 2026-02-15 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | -6,43k | 11,00k | Derivative Exercise and Sale | 1,71 | 145,80k | - |
| 2026-02-15 | Ms. Beth SmithVP, Controller & Treasurer | 672,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,78k | 5,55% |
| 2026-02-15 | Ms. Beth SmithVP, Controller & Treasurer | -423,00 | 723,33 | Derivative Exercise and Sale | 1,71 | 12,78k | - |
| 2026-02-15 | Mr. James KarrelsSenior VP & CFO | 9,21k | 0,00 | Derivative Exercise and Retained Stock | - | 206,04k | 4,68% |
| 2026-02-15 | Mr. James KarrelsSenior VP & CFO | -5,79k | 9,90k | Derivative Exercise and Sale | 1,71 | 206,04k | - |
| 2026-02-15 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | 8,19k | 0,00 | Derivative Exercise and Retained Stock | - | 31,11k | 35,71% |
| 2026-02-15 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | -5,15k | 8,80k | Derivative Exercise and Sale | 1,71 | 31,11k | - |
| 2026-02-15 | Dr. Thomas M. SpitznagelSVP of Technical Operations | 7,81k | 0,00 | Derivative Exercise and Retained Stock | - | 38,54k | 25,42% |
| 2026-02-15 | Dr. Thomas M. SpitznagelSVP of Technical Operations | -5,52k | 9,44k | Derivative Exercise and Sale | 1,71 | 38,54k | - |
| 2026-02-15 | Mr. Eric Blasius RisserCEO, President & Director | 10,23k | 0,00 | Derivative Exercise and Retained Stock | - | 77,17k | 15,29% |
| 2026-02-15 | Mr. Eric Blasius RisserCEO, President & Director | -6,43k | 11,00k | Derivative Exercise and Sale | 1,71 | 77,17k | - |
| 2026-02-15 | Dr. Scott KoenigDirector | 21,17k | 0,00 | Derivative Exercise and Retained Stock | - | 867,24k | 2,50% |
| 2026-02-08 | Dr. Scott KoenigDirector | 15,83k | 0,00 | Derivative Exercise and Retained Stock | - | 846,08k | 1,91% |
| 2026-02-07 | Dr. Thomas M. SpitznagelSVP of Technical Operations | 9,33k | 0,00 | Derivative Exercise and Retained Stock | - | 30,73k | 43,59% |
| 2026-02-07 | Dr. Thomas M. SpitznagelSVP of Technical Operations | -5,67k | 10,26k | Derivative Exercise and Sale | 1,81 | 30,73k | - |
| 2026-02-07 | Mr. Eric Blasius RisserCEO, President & Director | 10,95k | 0,00 | Derivative Exercise and Retained Stock | - | 66,94k | 19,55% |
| 2026-02-07 | Mr. Eric Blasius RisserCEO, President & Director | -6,89k | 12,46k | Derivative Exercise and Sale | 1,81 | 66,94k | - |
| 2026-02-07 | Ms. Beth SmithVP, Controller & Treasurer | 2,58k | 0,00 | Derivative Exercise and Retained Stock | - | 12,11k | 27,04% |
| 2026-02-07 | Ms. Beth SmithVP, Controller & Treasurer | -1,62k | 2,94k | Derivative Exercise and Sale | 1,81 | 12,11k | - |
| 2026-02-07 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | 9,21k | 0,00 | Derivative Exercise and Retained Stock | - | 22,92k | 67,17% |
| 2026-02-07 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | -5,79k | 10,48k | Derivative Exercise and Sale | 1,81 | 22,92k | - |
| 2026-02-07 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | 11,15k | 0,00 | Derivative Exercise and Retained Stock | - | 135,57k | 8,96% |
| 2026-02-07 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | -7,01k | 12,70k | Derivative Exercise and Sale | 1,81 | 135,57k | - |
| 2026-02-07 | Mr. James KarrelsSenior VP & CFO | 10,03k | 0,00 | Derivative Exercise and Retained Stock | - | 196,83k | 5,37% |
| 2026-02-07 | Mr. James KarrelsSenior VP & CFO | -6,31k | 11,41k | Derivative Exercise and Sale | 1,81 | 196,83k | - |
| 2025-08-19 | Dr. William K. HeidenIndependent Chairman of the Board | 100,00k | 150,52k | Achat | 1,49 - 1,52 | 111,00k | 909,09% |
| 2025-08-13 | Dr. Scott KoenigDirector | 52,83k | 0,00 | Derivative Exercise and Retained Stock | - | 830,24k | 6,80% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
